Introduction
Organometallic ruthenium(II) complexes are a family of ruthenium(II) compounds of interest as potential antitumor agents, [1] [2] [3] [4] [5] [6] [7] [8] [9] and for the type [(η 6 -arene)Ru(YZ)(X)][PF 6 ], where X is a halide and YZ is a chelating diamine such as ethylenediamine (en), have in vitro and in vivo anticancer activity, including cisplatin-resistant cell lines. [10] [11] [12] [13] The arene ligand occupies three coordination sites in these pseudo-octahedral complexes and stabilizes Ru in its +2 oxidation state. 14 For the family of chlorido en complexes [(η 6 -arene)Ru(en)Cl][PF 6 ], the cytotoxicity increases with the size of the coordinated arene, and the cytotoxicity of the p-cymene complex against human ovarian cancer cell line A2780 is comparable to that of carboplatin. 10, 12 DNA is a potential target for these ruthenium(II) arene complexes, most of which bind selectively to N7 of guanine. [15] [16] [17] [18] [19] [20] However, these organometallic ruthenium anticancer complexes also have a high affinity for the thiolate sulfur in cysteine, 21 glutathione 22 and human albumin, 23, 24 and Ru-S coordination can induce the oxidation of thiolates to sulfenates or sulfinates, [22] [23] [24] and subsequently stabilizes the sulfenato ligands 23, 25 which as free ligands are often unstable and highly reactive. 26, 27 Moreover, glutathione was shown 3 treatment of human breast and ovarian cancers, a significant subset of which, especially HER2/Neu HER2(+) tumors, overexpress PTP1B. 29, 30, 36 The catalytic site residue Cys215 plays a central role in modulating the activity of PTP1B, and is a key feature in the deactivation/reactivation pathway involving the formation and the subsequent reduction of a sulfenyl-amide intermediate mediated by the endogenous signaling molecules hydrogen peroxide (H 2 O 2 ) and glutathione (GSH), respectively. [37] [38] [39] [40] This intriguing behavior of PTP1B led us to explore whether ruthenium arene anticancer complexes coordinate to the catalytic thiol of PTP1B and inhibit enzyme activity via the induced oxidation of thiol to sulfinate/sulfenate and the subsequent stabilization of the sulfenate.
Indeed, in a preliminary study, we found that the ruthenium arene anticancer complex [( 6 -p-cym)Ru(en)Cl]PF 6 (1, cym = cymene) is inhibitory towards PTP1B
with an IC 50 of 19 M.
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In the present work, therefore, the thiol 2-mercaptobenanilide (2), and the product of H 2 O 2 -oxidation, the sulfenyl-amide and di-nuclear thiolato products, which were both characterized by X-ray diffraction analysis, were studied to mimic the effect of ruthenium coordination on the inactivation and reactivation of PTP1B.
Results

Synthesis and crystallographic characterization of 2 -mercaptobe nzanilide:
The model compound 2-mercaptobenzanilide (2) was synthesized following the procedure described in the literature, 38, 39, 42 and crystallized from a saturated solution in methanol. The X-ray structure and atom numbering scheme are depicted in Figure   1a , crystallographic data are listed in Table 1 , and selected bond lengths and angles in Table 2 . As expected, the distance between the sulfur atom (S1) of the thiol and the nitrogen atom (N1) of the amide in compound 2 (3.8 Å) is similar to that (3.5 Å) between the thiol group of Cys215 and the amide N of Ser216 at the active site of PTP1B.
37, 40, 43
To mimic the redox regulation of PTP1B, compound 2 (1 mM) was incubated with 1.4 mol equiv. of H 2 O 2 in 50 mM sodium phosphate buffer (pH 7.4) containing 30% MeCN, which was used to increase the solubility of compound 2 in the reaction mixture, at 298 K. This reaction immediately gave rise to a product as detected by (Table 3 and Figure S1 ), assignable to compound 2, its oxidized derivatives disulfide compound 3, sulfenyl-amide compound 4, sulfonic acid 5 and sulfinyl-amide compound 6 (Scheme 1), respectively. The mass spectra ( Figure S1 ) of peaks a and c showed that there is a 2 Da difference between the masses of species contained in these two peaks, indicating that this reaction afforded the expected sulfenyl-amide compound (4) which is analogous to the sulfenyl-amide intermediate formed after the H 2 O 2 -mediated inactivation of PTP1B.
37, 39, 40
We were also successful in crystallizing the sulfenyl-amide compound 2-phenyl-1,2-benzisothiazol-3(2H)-one (4) from a saturated ethanol solution. The X-ray structure is shown in Figure 1b , and the crystallographic data and the selected bond lengths and angles are listed in Tables 1 and 2 , respectively. Except for the formation of the new S1-N1 bond, there is little change in other bond lengths compared to 2. In compound 4, it is notable that the C1-N1-S1-C7-C2 ring is almost coplanar with the benzene ring (dihedral angle < 3 o ).
Then the purified sulfenyl-amide compound 4 (1 mM) was incubated with 10 equiv. mol of GSH in 50 mM phosphate buffer (pH = 7. glutathione thiolato complex was detectable in the reaction mixture incubated at 298 K for 48 h ( Figure S3 ).
The thiolato compound 7 was precipitated by adding NH 4 PF 6 to the equilibrium reaction mixture containing 5 mM 1 with one mol equiv 2 and recrystallized from dichloromethane/ether. Crystals suitable for X-ray analysis were obtained by slow evaporation of a dichloromethane/ether solution at 253 K. The crystallographic data for 7 are listed in Table 1 , and selected bond lengths and angles in Table 4 . As shown in Figure 3 , the coordination of Ru to the sulfur atom in 2 allows the formation of an H-bond between the NH of the en ligand and the carbonyl oxygen with a bond (NHOC) length of 2.02 Å ( Figure S4 ), indicative of a strong H-bonding. The Ru-S bond length (2.4059(9) Å) is slightly longer than that in the thiolato compound [( 6 -p-cymene)Ru(en)(S-C 6 H 6 )]I. 25 The thiolato complex 7 is soluble and stable in aqueous solution; ca. 94 % of 7 remained intact after 60 h incubation in phosphate buffer at 298 K ( Figure S5 Figure   S5 .
The pK a of the thiol of the model compound 2 is reported to be 5.7, similar to that of the active-site thiol in PTP1B (5.6). 39 The reaction of the protonated ligand 2 with the ruthenium complex was also investigated in 50 mM phosphate buffer containing 50% methanol at pH 5.3 which is similar to the pH in endosomes (5-6). Figure S2 ). This di-ruthenium thiolato complex was also precipitated by a similar procedure described above, washed with diethyl ether, and dried in vacuum. The crude mixture was then purified by flash column chromatography eluting with dichloromethane/methanol (11:0.2). Slow evaporation of the dichloromethane/methanol solvent gave rise to red crystals suitable for X-ray diffraction studies. The crystallographic data are listed in Table 1 , and selected bond lengths and angles in Table 3 . These results show that the di-nuclear product is a triply-S-bridged thiolato complex [(( 6 -cym)Ru) 2 Table 4) .
Reactions of thiolato adduct 7 with H 2 O 2 and GSH:
To provide a model for the H 2 O 2 -mediated oxidation and the subsequent GSH-mediated reduction, the thiolato ruthenium complex 7 (1 mM) was incubated with 1.4 mol equiv. of H 2 O 2 in phosphate buffer (pH =7.4, containing 30% MeCN) at 298 K, and the reaction was followed by HPLC coupled with ESI-MS. The HPLC time-course ( Figure 5a ) showed a minor product (peak c) after ca. 0.5 h, and then other two adducts (peaks h and e) after 1.5 h. Up to 7.5 h, peaks c, h and e slowly increased in intensity, but no obvious changes in intensity were observed for all three peaks after 12 h (Figure 5a ).
The subsequent ESI-MS analysis identified fractions c and e as containing the oxidized derivatives 4 (sulfenyl-amide) and 6 (sulfinyl-amide), respectively, as indicated by the singly-charged ion peaks at m/z 244.01 and 228.00 ( Figure S6 , Table   3 ). The inset in Figure 5a shows peak h having a shoulder, suggesting that this peak contains a mixture of products formed from the oxidation of complex 7, as evidenced by distinct UV-Vis spectra of fractions eluting at 5.00 and 5.05 min ( Figure S7 ). The mass spectra of these fractions ( Figure S6 , To mimic the effect of ruthenium coordination on the redox regulation of the catalytic thiol group in PTP1B, the mono-ruthenium thiolato complex (7) was first allowed to react with 1.4 mol equiv. H 2 O 2 in phosphate buffer (pH 7.4) for 24 h, and then 10 mol equiv.
GSH was added to the reaction mixture after removing excess H 2 O 2 by addition of catalase (260 units mL -1 ). The resulting mixture was incubated at 298 K and monitored by HPLC assay. As shown in Figure 5b , the sulfenyl-amide compound 4
(peak c) resulting from the oxidation of the dissociated thiolato ligand in 7 by H 2 O 2 was quickly reduced by GSH back to its initial form, i.e. the thiol compound 2 (peak a in Figure 5b ) which increased in concentration until 72 h. However, the sulfinato Ru(II) complex 10 and the thiolato Ru(III) complex 11 (peak h) resulting from the oxidation of complex 7, as well as the sulfinyl-amide compound 6 resulting from the oxidation of dissociated thiolate ligand in 7 by H 2 O 2 , remain intact in the presence of a 10-fold excess of GSH. The triply-glutathione-bridged diruthenium complex 13
(peak i) and a mixed-disulfide compound GS-S(C 6 H 6 )CONH(C 6 H 6 ) (17, peak j), as indicated by the mass spectra of these fractions (Table 3 , Figure S8 ), appeared in the HPLC chromatogram ( Figure 5b ) after 24 h of reaction.
At pH 5.3 thiolato complex 7 reacted with H 2 O 2 much more extensively than at 7.4. This reaction gave rise to a significant amount of the sulfenyl-amide compound 4
(peak c in Figure 6 ) which resulted from the oxidation of the dissociated thiolate ligand from 7, and a significant amount of the sulfinato Ru(II) complex 10 and the thiolato Ru(III) complex 11 (peak h in Figure 6 ). Meanwhile, the diaqua adduct Figure 6 ) formed after the dissociation of the en ligand became detectable after 12 h reaction and increased in content until 72 h, when only 11.7% of 7 remained intact ( Figure 6 ).
Notably, due to its low extinction coefficient at 260 nm, the aqua Ru arene adduct
resulting from the dissociation of the oxidized thiolate ligand was hardly detectable by HPLC ( Figure 6 ). Combining the above results, the pathway for the reaction of complex 7 with H 2 O 2 at pH 5.3 shown in Scheme 4 can be proposed.
To investigate whether the coordinated thiolate ligand in 7 can be released via direct substitution by GSH, the most abundant thiol-containing biomolecule inside cells, reaction of complex 7 (1 mM) with 10 mol equiv. of GSH in 50 mM phosphate buffer (pH =7.4, containing 30% MeCN at 298K) was also studied by HPLC coupled with ESI-MS. As shown in Figure 7a , during the early stages (< 0.5 h) no product was detectable by HPLC. A new HPLC peak (a in Figure 7a ) appeared after 6.5 h of reaction and increased in intensity until 72 h. This was identified as the free thiol-containing compound 2 by subsequent MS analysis ( Figure S10 , Table 3 ).
Meanwhile, after 12 h reaction, another product (peak k in Figure 7a ) became detectable and was identified by MS ( Figure S10 ) as the glutathione thiolato complex (12) . After 72 h of reaction, nearly 43% of the thiolato ligand in 7 was substituted by GSH (Figure 7a ), suggesting that GSH in 10-fold excess, can slowly displace the thiolato ligand from complex 7 (Scheme 5).
In weakly acidic solution (pH 5.3), as for the reaction of complex 7 with H 2 O 2 , the reaction of complex 7 with excess GSH also became extensive and complicated.
After 6 h incubation, this reaction gave rise to a glutathione thiolato-bridged diruthenium product [(( 6 -cym)Ru) 2 (GS) 3 ]  (13, appearing as peak i in Figure 7b ) and mono-ruthenium thiolato complex was still the main product, indicating that complex 1 has a higher affinity for the thiol in 2 than for GSH. This might imply that PTP1B
would form stronger adducts than GSH with ruthenium complex 1 in cells.
The crystallographic data (Table 4 , Figure 3) show that the coordination of Ru with the sulfur atom in 2 allows the formation of a strong H-bond (NHOC length:
2.02 Å, Figure S4 ) between the NH of en ligand and the carbonyl oxygen, which may account for the higher stability of the ruthenium adduct with compound 2 compared to GSH. The thiolato adduct with 2 (complex 7) is soluble and stable in aqueous solution (pH 7.4), only 6% of 7 hydrolyzes after 60 h incubation at 298 K ( Figure S5 ).
However, at pH 5.3, nearly 15% of 7 hydrolyzed after 60 h incubation. Interestingly, the hydrolysis involved the displacement of the en ligand instead of the thiolate ligand, affording the di-aqua adduct 9 (Scheme 3, Figure S5 ). Sulfur-containing ligands such as cysteine and methionine are known to exhibit high trans effects in Pd(II) 48 , Pt(II) 49 and Ru(II) 21 coordination chemistry, labilizing metal-N bonds in the trans position.
On the other hand, at low pH the ethylenediamine (en) ligand is readily protonated, making it a better leaving group, accounting for the dissociation of en from complex 7 in weakly acidic solutions. This trans effect imposed by S coordination to Ru was also observed in the reaction of complex 1 with the thiol compound 2, and complex 7 the small amount of sulfenyl-amide compound 4 resulting from the oxidation of the dissociated thiolate group from 7 was quickly reduced back to its initial form, compound 2, accompanied with the formation of small amount of triply-glutathione-bridged diruthenium complex 13 and mixed disulfide compound GS-S(C 6 H 6 )CONH(C 6 H 6 ) (17). The diruthenium complex 13 formed through the directly substitution of the thiolato ligand in 7 by GSH, leading to the further release of the thiolato ligand in 7 (Figure 5b ) such that only ca. 10% of thiolato complex 7 was present in its initial form after 72 h reaction (Figure 7b ). These data imply that under physiological conditions, intracellular GSH may activate the thiolate in 7 by displacing the thiolato ligand, though the ligand exchange is very slow (Figure 5 ).
At pH 5.3, the dissociation of the en ligand from 7 allowed formation of more glutathione-bridged diruthenium adduct 13 and mixed-thiolate-bridged adducts 14 and
15.
However, the amount of the free thiol compound 2 released from 7 did not increase compared with that formed at pH 7.4 ( Figure 7 ).
Conclusions
The mercaptobenanilide compound 2 and its oxidized derivative the sulfenyl-amide compound 4 are models for species which form in the active site of the enzyme 
HPLC-ESI-MS
Positive-ion electrospray ionisation mass spectra were obtained on a Micromass Q-TOF mass spectrometer (Waters) coupled to Agilent 1200 HPLC system using XDB-C18 column (4.6×150mm, 80Å, 5 μm, Agilent) with a flow rate of 1.0 mL min respectively. The collision energy was set up to 9.9 V. All spectra were acquired in the range of 100 -2000 m/z. Data were collected and analyzed on a Mass Lynx (ver.
4.0).
X-ray crystallography
Single-crystal X-ray diffraction studies for 2-mercaptobenzanilide (2) and 2-phenyl-1,2-benzisothiazol-3(2H)-one (4) were carried out us ing graphite 
PTP1B Inhibition Assay
Following a similar procedure to that described in the literuture, 52 were stopped by addition of 5 µL of 1 M NaOH, and the absorption was determined at 405 nm. Nonenzymatic hydrolysis of the substrate was corrected by measuring the control samples without addition of enzyme. IC 50 values were generated by fitting the concentration-dependent inhibition curves using the program Origin (ver 7.5). All data points were obtained in sextuplicate. 
Notes and References
, where n = number of reflections and p = number of parameters. Table 2 Selected bond lengths (Å) and angles (°) for 2-mercaptobenzanilide (2), 2-phenyl-1,2-benzisothiazol -3(2H)-one (4). For numbering schemes see Figure 1 .
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S1-C6 [b] Observed (Obs) and calculated (Calcd) mass-to-charge ratios for the most abundant iostope of observed ions. For mass spectra see Figures S1-S4 and S6-S7.
[c] H indicates gain (+) or loss (-) of a proton.
[d] The fraction contains a mixture of products 10 and 11.
[e] Complex 7 firstly reacted with with H 2 O 2 for 24 h and then added GSH into the reaction mixture for further reaction for 72 h after removing excess of H 2 O 2 by addition of catalase.
[f] 17 = RS-SG, R = C 6 H 5 CONHC 6 H 4.
[ Figure S5 . Peak assignments: c, 4; e, 6; f, 7  ; g, 9 + ; and h, 10 + and 11
2+
.
Mass spectra for all fractions are shown in Figure S9 . K for 24 h, with 10 mol equiv. GSH after removing excess of H 2 O 2 using catalase.
The inset g indicates that the shoulder on peak h contains a mixture of two adducts as evidenced by the distinct UV-Vis spectra corresponding to fractions eluting at 5.00 
